Biologist by training at Ecole Normale Supérieure de Paris (1974-1978), Lluis M. Mir did all his career at the Centre National de la Recherche Scientifique (1978-2019). His field, deciphering the effects of pulsed electric fields on cells and organisms, is at the cross of several disciplines (bioelectricity, bioelectromagnetism, bioelectrochemistry). His research resulted in new medical applications such as cancer treatment by electrochemotherapy. He was the director of the Laboratory of Vectorology and Anticancer Therapies (CNRS, University Paris-Sud and Gustave-Roussy)(2010-2019) and of the International Associated Laboratory on the Pulsed Electric Fields Applications in Biology and Medicine (2011-2018).
He has been President of the European Bioelectromagnetics Association (2013-2015), the International Society for the Electroporation-Based Technologies and Treatments (2020-2022) and URSI-France (2022-2024). He was Visiting Professor at the Universities of Bielefeld (Germany), Berkeley (California) and Jerusalem (Israel). Fellow of the AIMBE (American Institute for Medical and Biological Engineering) and URSI (International RadioScience Union), he was awarded three Honoris Causa Doctorates in 2018, by the Universities San Marcos of Lima (Perou), Buenos Aires (Argentina) and Ljubljana (Slovenia). He also received the 2017 URSI’s Balthazar van der Pol Gold Medal, the 2015 F. Reidy Award in Bioelectrics and the 2021 G. Milazzo Prize in Bioelectrochemistry.
The page has been updated in May 2024.
